Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Florida
About this trial
Stigma due to health conditions increases disease burden and adversely impacts health. The internalization of health-related stigma is associated with impaired mental health and quality of life. The current project will test the effects of a novel, transdiagnostic, group counseling intervention, and peer support, to determine the optimal method for helping patients cope with health-related stigma, reducing its internalization, and enhancing patient quality of life.
Eligibility criteria
Qualifiers
Age 18 years or older
Obesity (or high body weight that negatively affects health)
Skin disease (including but not limited to psoriasis, eczema, or vitiligo)
Cancer (including but not limited to lung, breast, cervical, colorectal, gynecologic, prostate, or head and neck; including individuals in remission)
Disqualifiers
Current or recent (e.g., past 3 months) receipt of psychotherapy or a psychosocial or peer support intervention (exceptions may be made if therapy or support is not focused on health conditions and is unlikely to affect internalized health-related stigma; e.g., family or marriage counseling, religious study groups, etc.)
Psychiatric hospitalization in the past 6 months
Recent (e.g., past 3 months, approximately) change in medications taken for psychiatric reasons
Current, active suicidal thoughts or suicide attempt within the past year
Trial design
Treatments tested in this trial
- Healing HEARTS
- Peer Support
Treatment groups
195 Participants
are divided into 3 treatment groupsSponsors and collaborators
University of Florida
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
National Institutes of Health (NIH)
Collaborator
Source ClinicalTrials.gov